Medications Updated During May 2011, From Newest to Oldest, Page 5

Page 5 of 19 « First Page « … 3 4 5 6 7 … 10 15 … » Last Page »

UR N-C Urinary Antiseptic (Hyoscyamine Sulfate, Methenamine, Phenyl Salicylate, Sodium Phosphate Monobasic, Methylene Blue)

UR N-C is indicated for the treatment of symptoms of irritative voiding. Indicated for the relief of local symptoms, such as inflammation, hypermotility, and pain, which accompany lower urinary tract infections. Indicated for the relief of urinary…

Libertas Pharma, Inc.21 May 2011

Anticoagulant Sodium Citrate (Sodium Citrate)

For use with automated plasmapheresis equipment only. Use according to equipment manufacturer’s instructions. This unit should be used for plasmapheresis only. WARNINGS. Not for direct intravenous infusion. DO NOT VENT. Avoid excessive heat. Protect…

Medsep Corporation20 May 2011

Phrenilin (Butalbital and Acetaminophen)

PHRENILIN tablets and PHRENILIN FORTE capsules are indicated for the relief of the symptom complex of tension (or muscle contraction) headache. Evidence supporting the efficacy and safety of this combination product in the treatment of multiple…

Valeant Pharmaceuticals International20 May 2011

Sulfamethoxazole and Trimethoprim

To reduce the development of drug-resistant bacteria and maintain the effectiveness of sulfamethoxazole and trimethoprim tablets and other antibacterial drugs, sulfamethoxazole and trimethoprim should be used only to treat or prevent infections that…

UDL Laboratories, Inc.20 May 2011

Lorazepam

Lorazepam tablets are indicated for the management of anxiety disorders or for the short-term relief of the symptoms of anxiety or anxiety associated with depressive symptoms. Anxiety or tension associated with the stress of everyday life usually…

RedPharm Inc.20 May 2011

Page 5 of 19 « First Page « … 3 4 5 6 7 … 10 15 … » Last Page »

FDA Medwatch

BD Announces FDA Classifications for August 4th Recalls of BD Alaris™ System Hardware for Keypads, Incorrect Module Types and/or Sizes, and Channel Error
Sun, 20 Sep 2020. Three of the recalls, which BD announced on Aug. 4, 2020, have been designated as Class I recalls by the U.S. Food and Drug Administration (FDA), which means that FDA has determined that there is a reasonable probability that the use of the product…
Acella Pharmaceuticals, LLC Issues Voluntary Nationwide Recall of Two Lots of NP Thyroid®, Thyroid Tablets, USP Due to Sub Potency
Wed, 16 Sep 2020. Acella Pharmaceuticals, LLC is voluntarily recalling one lot of 15-mg and one lot of 120-mg NP Thyroid®, Thyroid Tablets, USP [levothyroxine (T4) and liothyronine (T3)] to the consumer level. The products are being recalled because testing has…

MedLibrary.org

Medication Sections

RSS Feeds

About

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.